Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Class Effect on Microbiome After Gastric Bypass
NCT05367479Phase 1Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Jul 2018
- Primary completion
- Jan 2020
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in surgical site infection (SSI) and hypertension (HTN) comparing Cefazolin with Clindamycin (2 arms). Primary endpoint: Operational Taxonomic Units. Started Jul 2018; status: completed.
02
Drugs
cefazolinclindamycin
03
Conditions
surgical site infection (SSI)hypertension (HTN)
Beyond the preview
Go deeper on NCT05367479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05367479.